Postsurgical and Upex-Med just receive a notice of issuance of patent application from the USPTO (US #11,793,762) Postsurgical Therapeutics
Postsurgical begins its key in vitro and in vivo tests with MYER RESEARCH Inc. for a combination of everolimus and trametinib Postsurgical Therapeutics